These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38124429)

  • 1. Cannabis vaporisation: Understanding products, devices and risks.
    MacCallum CA; Lo LA; Pistawka CA; Christiansen A; Boivin M
    Drug Alcohol Rev; 2024 Mar; 43(3):732-745. PubMed ID: 38124429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaping preferences of individuals who vaporise dry herb cannabis, cannabis liquids and cannabis concentrates.
    Morgan J; Gschwend G; Houston M; Jones A; Kelso C
    Drug Alcohol Depend; 2022 Nov; 240():109632. PubMed ID: 36152405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Coombs M; Najafizada M; Bishop LD
    Appl Health Econ Health Policy; 2023 Jul; 21(4):651-659. PubMed ID: 37060511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.
    Hammond D
    Int J Drug Policy; 2021 May; 91():102509. PubMed ID: 31351756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic Nicotine Delivery Systems and E-Liquid Modifications to Vape Cannabis Depicted in Online Videos.
    Ouellette RR; Selino S; Kong G
    JAMA Netw Open; 2023 Nov; 6(11):e2341075. PubMed ID: 37917060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Vaping: From the Dangers of Misuse to New Therapeutic Devices.
    Varlet V
    Toxics; 2016 Dec; 4(4):. PubMed ID: 29051432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging adult perceptions of higher-risk cannabis consumption behaviours.
    McMahon I; Harris-Lane LM; Donnan J; Bishop L; Harris N
    Harm Reduct J; 2023 Sep; 20(1):127. PubMed ID: 37679733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a Vaping Machine for the Sampling of THC and CBD Aerosols Generated by Two Portable Dry Herb Cannabis Vaporisers.
    Carrara L; Giroud C; Concha-Lozano N
    Med Cannabis Cannabinoids; 2020 Aug; 3(1):84-93. PubMed ID: 34676343
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Application of Cannabis Vaporization: Examining Safety and Best Practices.
    MacCallum CA; Lo LA; Boivin M
    Cannabis Cannabinoid Res; 2024 Feb; ():. PubMed ID: 38394323
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaping cannabis (marijuana): parallel concerns to e-cigs?
    Budney AJ; Sargent JD; Lee DC
    Addiction; 2015 Nov; 110(11):1699-704. PubMed ID: 26264448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury.
    Boakye E; El Shahawy O; Obisesan O; Dzaye O; Osei AD; Erhabor J; Uddin SMI; Blaha MJ
    PLoS One; 2022; 17(10):e0276187. PubMed ID: 36251673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing the science on cannabis concentrates and behavioural health.
    Bidwell LC; Martin-Willett R; Karoly HC
    Drug Alcohol Rev; 2021 Sep; 40(6):900-913. PubMed ID: 33783029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products?
    Rossheim ME; LoParco CR; Henry D; Trangenstein PJ; Walters ST
    J Stud Alcohol Drugs; 2023 May; 84(3):357-360. PubMed ID: 36971760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.
    Lineham J; Wadsworth E; Hammond D
    Drug Alcohol Rev; 2023 Jul; 42(5):1142-1152. PubMed ID: 37062952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cannabis-infused edibles on public safety and regulation.
    Peralt A; Ke P; Castaneto MS
    J Forensic Sci; 2022 Nov; 67(6):2387-2393. PubMed ID: 36097671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration.
    Freeman TP; Lorenzetti V
    Addiction; 2020 Jul; 115(7):1207-1216. PubMed ID: 31606008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Substances Are Adolescents Vaping? Estimating Nicotine-Specific and Cannabis-Specific Vaping from US National Youth Surveys.
    Selya A; Kim S; Shiffman S; Gitchell J; Foxon F
    Subst Use Misuse; 2024; 59(2):218-224. PubMed ID: 37838985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Synthetic cannabis': A dangerous misnomer.
    Darke S; Banister S; Farrell M; Duflou J; Lappin J
    Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.
    Dai HD; Subramanian R; Mahroke A; Wang M
    JAMA Netw Open; 2023 Aug; 6(8):e2329167. PubMed ID: 37585202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.